Rilapladib
Rilapladib (SB 659032) is a potent and selective inhibitor of Lp-PLA2 (IC50 = 230 pM) and a platelet-activating factor receptor antagonist. This small molecule is a valuable research tool for investigating atherosclerosis and neuroinflammation in both cellular and animal models.
Product Specifications
CAS Number
412950-08-4
Product Name Alternative
Lp-PLA2, SB 659032, SB659032, SB-659032, Rilapladib
Field of Research
Metabolism Research
Purity
97.29% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (2.72 mM) ; DMSO:78 mg/mL (106.01 mM)
Smiles
COCCN1CCC (CC1) N (Cc1ccc (cc1) -c1ccc (cc1) C (F) (F) F) C (=O) Cn1c (SCc2cccc (F) c2F) cc (=O) c2ccccc12
Molecular Formula
C40H38F5N3O3S
Molecular Weight
735.8
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
